United States· US:71179-816_ed5a625e-a3a7-4d6a-83fd-78de2a2473b8
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS
A antiinflammatory products for vaginal administration product containing naproxen sodium and pseudoephedrine hydrochloride, registered in United States by VESPYR BRANDS LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Naproxen Sodium and Pseudoephedrine Hydrochloride
- Manufacturer
- VESPYR BRANDS LLC
- Country
- United States (US)
- ATC code
- G02CC
- ATC class
- Antiinflammatory products for vaginal administration
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1171179816243 BLISTER PACK in 1 CARTON (71179-816-24) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc2d64e6-8892-47e5-8744-aed958b51334 GET /v1/drugs/bc2d64e6-8892-47e5-8744-aed958b51334?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "9TN87S3A3C",
"rxcui": "142442",
"inchikey": "CDBRNDSHEYLDJV-FVGYRXGTSA-M",
"display_name": "NAPROXEN SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"c5146d73-2f34-4dfe-ac29-97071279dc4d": {
"match": "brand_token",
"title": "NAPROXEN SODIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]",
"spl_version": "10",
"published_date": "2026-05-28"
}
},
"productid": "71179-816_ed5a625e-a3a7-4d6a-83fd-78de2a2473b8",
"productndc": "71179-816",
"dosage_form": "TABLET, EXTENDED RELEASE",
"orange_book": {
"appl_no": "211360",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "220MG;120MG",
"product_no": "001",
"approval_date": "Jun 1, 2022"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE",
"proprietary_name": "NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA211360",
"marketing_category": "ANDA",
"nonproprietary_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride",
"start_marketing_date": "20240807",
"active_numerator_strength": "220; 120"
}See everything about naproxen sodium and pseudoephedrine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.